Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Liraglutide recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Liraglutide (4 total). Check the affected lots below.

Most common reason: Temperature excursion (3 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Liraglutide. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Liraglutide recalls in 2026

1 initiated in 2026, 4 in total — newest first
Class I · High risk

Xultophy 100/3.6

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-2911-90 D-0623-2021
Class II · Moderate risk

ViCTOZA (liraglutide)

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-4060-90 D-0622-2021
Class II · Moderate risk

Saxenda (liraglutide)

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-2800-90 D-0618-2021